Health Care

Sanofi India Ltd Q4 CY21 Earnings Conference Call Insights

● Mar 7, 2022

Key highlights from Sanofi India Ltd (SANOFI) Q4 CY21 Earnings Concall Q&A Highlights: Vipul Shah of RippleWave Equity asked if...

Sanofi India Ltd (SANOFI) Q4 FY21 Earnings Concall

● Mar 2, 2022

Sanofi India Ltd (NSE:SANOFI) Q4 FY21 Earnings Concall dated Mar. 02, 2022

Prevest Denpro Limited Q3 FY22 Earnings Conference Call Insights

● Mar 2, 2022

Key highlights from Prevest Denpro Limited (PREVEST) Q3 FY22 Earnings Concall Q&A Highlights: Pranay Jain from Dealwell Capital asked that...

Cupid Limited Q3 FY22 Earnings Conference Call Insights

● Mar 2, 2022

Key highlights from Cupid Limited (CUPID) Q3 FY22 Earnings Concall Management Update: CUPID stated that the top and bottom line...

Orchid Pharma Ltd Q3 FY22 Earnings Conference Call Insights

● Feb 22, 2022

Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY22 Earnings Concall Q&A Highlights: Viraj Kacharia  from Securities Investment asked about...

JB Chemicals & Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights

● Feb 17, 2022

Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY22 Earnings Concall Management Update: The company outperformed the sector...

MedPlus Health Services Ltd Q3 FY22 Earnings Conference Call Insights

● Feb 17, 2022

Key highlights from MedPlus Health Services Ltd (MEDPLUS) Q3 FY22 Earnings Concall Management Update: The company opened over 537 stores...

Glenmark Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights

● Feb 16, 2022

Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY22 Earnings Concall Management Update: GLENMARK stated the India business continues to...

Sequent Scientific Limited Q3 FY22 Earnings Conference Call Insights

● Feb 15, 2022

Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY22 Earnings Concall Management Update: SEQUENT saw significant improvement in the API...

Divi’s Laboratories Ltd Q3 FY22 Earnings Conference Call Insights

● Feb 14, 2022

Key highlights from Divi’s Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Concall Management Update: The company capitalized INR196 crores in 3Q22...